• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects on recipients of exposure to allogeneic donor leukocytes.

作者信息

Dzik W H

机构信息

Blood Bank and Tissue Typing Laboratory, Deaconess Hospital, Boston, Massachusetts 02215.

出版信息

J Clin Apher. 1994;9(2):135-8. doi: 10.1002/jca.2920090209.

DOI:10.1002/jca.2920090209
PMID:7798162
Abstract

Blood transfusion recipients are exposed to allogeneic donor leukocytes at the time of transfusion. Exposure to allogeneic donor leukocytes has been linked to a variety of complications of transfusion including primary HLA alloimmunization and platelet refractoriness, febrile nonhemolytic transfusion reactions, transmission of leukotropic viruses, transfusion-associated graft versus host disease, and transfusion-induced immune suppression. The development of high-performance leukodepletion blood filters and of low-leukocyte plateletapheresis machines has provided the technology to reduce recipient exposure to allogeneic donor leukocytes. This article provides a brief review of current information on the utility and shortcomings of these technologies for the prevention of leukocyte-mediated transfusion complications.

摘要

相似文献

1
Effects on recipients of exposure to allogeneic donor leukocytes.
J Clin Apher. 1994;9(2):135-8. doi: 10.1002/jca.2920090209.
2
Biologic effects of leukocytes present in transfused cellular blood products.
Blood. 1994 Sep 15;84(6):1703-21.
3
An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion.同种异体供体血小板不应性的动物模型:白细胞去除时间的影响。
Blood. 1992 Mar 1;79(5):1371-5.
4
[Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products].
Vnitr Lek. 1995 Oct;41(10):713-8.
5
Clinical aspects of platelet transfusion.血小板输注的临床方面。
Blood Coagul Fibrinolysis. 1992 Oct;3(5):643-6. doi: 10.1097/00001721-199210000-00020.
6
Leukocyte reduction in blood component therapy.血液成分治疗中的白细胞去除术。
Ann Intern Med. 1992 Jul 15;117(2):151-62. doi: 10.7326/0003-4819-117-2-151.
7
[Clinical applications of leukocyte filters].
Rev Assoc Med Bras (1992). 1997 Jul-Sep;43(3):205-8. doi: 10.1590/s0104-42301997000300007.
8
The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions.去除细胞血液制品中的白细胞以预防HLA同种免疫和对异体血小板输注的不应答。
Blood. 1995 Feb 1;85(3):603-6.
9
The use of leukocyte-reduced blood components.使用去白细胞血液成分。
Hematol Oncol Clin North Am. 1995 Feb;9(1):69-90.
10
[The efficacy of leukodepleted platelet transfusion].
Nihon Rinsho. 1997 Sep;55(9):2385-91.